HOW DO GLUCOCORTICOIDS, BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS AND DISEASE ACTIVITY IMPACT THE RISK OF STAPHYLOCOCCUS AUREUS BACTEREMIA IN RHEUMATOID ARTHRITIS PATIENTS? A NATIONWIDE NESTED CASE CONTROL STUDY IN THE DANISH DANBIO COHORT

S. Dieperink, B. Glintborg, F. Mehnert, M. Nørgaard, T. Benfield, C. Torp-Pedersen, L. B. Østergaard, A. Petersen, M. L. Hetland

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

33 Downloads (Pure)
OriginalsprogEngelsk
TidsskriftAnnals of the Rheumatic Diseases
Vol/bind81
Sider (fra-til)571
Antal sider1
ISSN0003-4967
DOI
StatusUdgivet - 2022

Citationsformater